Bethesda, MD, United States of America

Majda Haznadar


 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: Majda Haznadar: Innovator in Cancer Diagnosis and Prognosis

Introduction

Majda Haznadar is a prominent inventor based in Bethesda, MD (US). She has made significant contributions to the field of cancer research, particularly in the diagnosis and prognosis of cancer. With a total of 2 patents, her work is paving the way for advancements in medical diagnostics.

Latest Patents

Haznadar's latest patents focus on innovative methods for diagnosing cancer. One of her key inventions provides methods and materials for diagnosing cancer in individuals using tissue, blood, or urine samples. The method involves determining the levels of specific metabolites, including creatine riboside, metabolite 561+, cortisol sulfate, and N-acetylneuraminic acid. Additionally, her invention offers a way to determine the prognosis of cancer patients by analyzing these metabolites. The patents also include kits designed for detecting cancer and assessing the prognosis of patients.

Career Highlights

Majda Haznadar is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her role at this esteemed institution allows her to contribute to groundbreaking research and development in the medical field.

Collaborations

Throughout her career, Haznadar has collaborated with notable colleagues, including Ewy Mathe and Andrew D. Patterson. These collaborations have further enhanced her research and innovation in cancer diagnostics.

Conclusion

Majda Haznadar's work in cancer diagnosis and prognosis exemplifies her commitment to advancing medical science. Her innovative patents and collaborations are instrumental in improving cancer detection and patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…